N4-(1H-indazol-6-yl)-N2-[3-methoxy-4-(4-methylpiperazin-1-yl)phenyl]-5-methyl-pyrimidine-2,4-diamine

ID: ALA5173185

PubChem CID: 156704697

Max Phase: Preclinical

Molecular Formula: C24H28N8O

Molecular Weight: 444.54

Names and Identifiers

Canonical SMILES:  COc1cc(Nc2ncc(C)c(Nc3ccc4cn[nH]c4c3)n2)ccc1N1CCN(C)CC1

Standard InChI:  InChI=1S/C24H28N8O/c1-16-14-25-24(29-23(16)27-18-5-4-17-15-26-30-20(17)12-18)28-19-6-7-21(22(13-19)33-3)32-10-8-31(2)9-11-32/h4-7,12-15H,8-11H2,1-3H3,(H,26,30)(H2,25,27,28,29)

Standard InChI Key:  PCQOIBJOKXSDEB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    0.0809    0.2098    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7955    0.6221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5074    0.2102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5074   -0.6148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7973   -1.0266    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0809   -0.6185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6337   -1.0312    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3483   -0.6185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0631   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7752   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7752    0.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0649    0.6183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3483    0.2101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2220   -1.0275    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9367   -0.6148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6515   -1.0273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3635   -0.6153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3635    0.2101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6532    0.6220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9367    0.2138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2220    0.6228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1485   -0.8703    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1485    0.4651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6337   -0.2026    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4898    0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2044    0.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9190    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9190    1.4442    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2044    1.8568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4898    1.4442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6337    1.8568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4898   -1.0315    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4898   -1.8568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  6  7  1  0
  7  8  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
  8 13  1  0
  4 14  1  0
 14 15  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 15 20  1  0
  3 21  1  0
 17 22  1  0
 18 23  1  0
 23 24  2  0
 24 22  1  0
 25 11  1  0
 25 26  1  0
 27 26  1  0
 28 27  1  0
 29 28  1  0
 25 30  1  0
 30 29  1  0
 28 31  1  0
 10 32  1  0
 32 33  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5173185

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 444.54

Molecular Weight (Monoisotopic): 444.2386

AlogP: 3.91

#Rotatable Bonds: 6

Polar Surface Area: 94.23

Molecular Species: NEUTRAL

HBA: 8

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.82

CX Basic pKa: 7.54

CX LogP: 3.84

CX LogD: 3.46

Aromatic Rings: 4

Heavy Atoms: 33

QED Weighted: 0.41

Np Likeness Score: -1.62

References

1. Chen X, Liu L, Liu P, Chen Y, Lin D, Yan H, Yan Q, Wang Y, Qiu Y, Fang B, Huang H, Qian J, Zhao Y, Du Z, Zhang Q, Li X, Zheng X, Liu Z..  (2022)  Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the Treatment of Osteosarcoma.,  65  (7.0): [PMID:35239349] [10.1021/acs.jmedchem.1c01732]

Source

Source(1):

• Scientific Literature